Centre for Prevention of Stroke and Dementia
We increase understanding of the causes of cerebrovascular disease and improve the prevention of stroke and vascular dementia in routine clinical practice.
For Clinicians
Contact
t: 01865 231601
The Centre for the Prevention of Stroke and Dementia was founded as the Stroke Prevention Research Unit in 2000 by Professor Peter Rothwell with initial funding from the MRC and the Stroke Association.
Now comprising about 30 researchers and support staff, the centre is regarded as one of the most productive stroke research groups in the world. In summer 2019, it moves into a purpose-built new facility on the John Radcliffe Hospital site.
What's new
Our researchers test ‘Viagra’ drug to prevent recurrent strokes
17 January 2020
Researchers in our Centre for the Prevention of Stroke and Dementia have begun a clinical trial to assess whether the drug sildenafil could improve blood flow to the brain.
Masonic Charitable Foundation Fund Studentship at Centre for the Prevention of Stroke and Dementia
13 September 2019
The charity has provided £126K of funding for one 3-year clinical research fellowship starting in January 2020.
Risk of dementia after TIA or stroke
2 May 2019
Risk of dementia after stroke is a major concern for patients and carers. Reliable data on risk of dementia, particularly after TIA or minor stroke, are scarce.
Research Projects
Selected Publications
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
Pendlebury ST. et al, (2019), Lancet Neurol, 18, 248 - 258
Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis
Mazzucco S. et al, (2018), The Lancet Neurology, 17, 609 - 617
Medical Attention Seeking After Transient Ischemic Attack and Minor Stroke Before and After the UK Face, Arm, Speech, Time (FAST) Public Education Campaign
Wolters FJ. et al, (2018), JAMA Neurology
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Rothwell PM. et al, (2018), The Lancet, 392, 387 - 399
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
Li L. et al, (2017), The Lancet, 390, 490 - 499
Head
-
Peter Rothwell
Head of the Centre for the Prevention of Stroke and Dementia and Professor of Clinical Neurology
Stroke and heart disease research needs you!
Could you spare an hour to help our research?
Carotid Stenosis Tool
Helps to predict stroke risk